-transparent.png){kind=logo}
Newly developed somatostatin analogues may be useful agents in the treatment of breast and prostate cancer. Potential mechanisms of antitumor action include suppression of circulating levels of trophic hormones and growth factors as well as direct effects at the tumor level, potentially involving autocrine/paracrine mechanisms. Pilot clinical trials conducted in heavily pretreated women with advanced breast cancer indicate that SMS 201-995 (Sandostatin R) has minimal toxicity and moderately suppresses stimulated growth hormone secretion and basal somatomedin-C level. Somatostatin analogues have also been found to retard the growth of experimental prostate cancer, particularly when used in combination with LHRH analogues. The therapeutic efficacy of these compounds used alone or in combination with other agents in the treatment of breast and prostate cancer remains to be established in larger clinical trials involving less heavily pretreated patients.
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
January 1997,
The Yale journal of biology and medicine,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
January 2008,
Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
April 2001,
Annals of surgical oncology,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
September 2016,
Nuclear medicine and biology,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
January 1993,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
March 1991,
Annals of surgery,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
November 2004,
The Journal of urology,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
August 1987,
European journal of clinical investigation,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
September 1994,
Annals of the New York Academy of Sciences,
A Manni, and
A E Boucher, and
L M Demers, and
H A Harvey, and
A Lipton, and
M A Simmonds, and
M Bartholomew
March 1990,
Bailliere's clinical endocrinology and metabolism,
